Characteristics | Number (%) |
---|---|
Baseline age in year (n = 937) | |
18–25 | 173 (18.5) |
26–30 | 267 (28.5) |
31–40 | 332 (35.5) |
41–50 | 114 (12.2) |
51–71 | 51 (5.4) |
Sex (n = 937) | |
Female | 530 (56.6) |
Male | 407 (43.4) |
Residence | |
Bahir Dar and neighboring towns | 585 (62.4) |
Others | 352 (37.6) |
Baseline functional status (n = 937) | |
Working | 642 (68.5) |
Ambulatory | 246 (26.3) |
Bedridden | 49 (5.2) |
Baseline WHO clinical stage (n = 937) | |
Stage I | 44 (4.7) |
Stage II | 133 (14.2) |
Stage III | 655 (69.9) |
Stage IV | 105 (11.2) |
First treatment class (n = 937) | |
AZT-3TC | 553 (59.0) |
D4t-3TC | 29 (3.1) |
D4t (30) | 355 (37.9) |
Baseline CD4 count in cells/mm3 (n = 937) | |
<200 | 757 (80.8) |
200–349 | 172 (18.3) |
350–499 | 8 (0.9) |